Editas Medicine, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-163.8M | $-171.8M | $8.0M | $43.4M |
| FY2022 | $-177.3M | $-181.5M | $4.1M | $29.3M |
| FY2023 | $-132.2M | $-136.9M | $4.7M | $19.8M |
| FY2024 | $-210.3M | $-219.1M | $8.8M | $21.4M |
| FY2025 | $-165.2M | $-165.8M | $607.0K | $10.0M |